.
may 16, 2018
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Lacoss-brother-of-Baena-from-Beijing?Stangebro=236
![](/b98584f181.site.internapcdn.net/tmpl/v5/img/1x1.gif)
.
.